Clinical trial
Acceptability of a Fixed Combination of Fenofibrate and Metformin
NCT00348725 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00348725 |
|---|---|
| Title | Acceptability of a Fixed Combination of Fenofibrate and Metformin |
| Official title | An Open Label, Parallel-Arm, Multicenter Trial Assessing the Acceptability of 4 Dosages of a New Fixed Dose Combination of Fenofibrate and Metformin in Patients With Type 2 Diabetes and Dyslipidemia |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia/Glucose Metabolism Disorder |
| Intervention type | Drug |
| Interventions | fenofibrate and metformin fixed combination (drug) |
| Enrollment | 69 |
| Start date | Apr 1, 2005 |
| First posted | Jul 6, 2006 |
| Last update posted | Sep 3, 2007 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: